Prof. Dr. Scott McNeil

Hemmrich, Eva, & McNeil, Scott. (2024). Strategic aspects for the commercialization of nanomedicines [Journal-article]. Journal of Controlled Release, 369, 617–621. https://doi.org/10.1016/j.jconrel.2024.04.003

Hemmrich, Eva, & McNeil, Scott. (2023). Active ingredient vs excipient debate for nanomedicines. Nature Nanotechnology, 18, 692–695. https://doi.org/10.1038/s41565-023-01371-w

Adiseshaiah, Pavan P., Crist, Rachael M., Hook, Sara S., & McNeil, Scott E. (2016). Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer. Nature Reviews Clinical Oncology, 13, 750–765. https://doi.org/10.1038/nrclinonc.2016.119

Dobrovolskaia, Marina A., & McNeil, Scott E. (2016). Handbook of immunological properties of engineered nanomaterials: Second edition (Vol. 1-3). https://doi.org/10.1142/9677

Tinkle, Sally, McNeil, Scott E., Mühlebach, Stefan, Bawa, Raj, Borchard, Gerrit, Barenholz, Yechezkel Chezy, Tamarkin, Lawrence, & Desai, Neil. (2014). Nanomedicines: addressing the scientific and regulatory gap. Annals of the New York Academy of Sciences, 1313, 35–56. https://doi.org/10.1111/nyas.12403